Rewriting the Neuroscience Playbook
June 23, 2026
Merz Therapeutics is exploring botulinum toxin in chronic pain – a test case for unconventional thinking in neuroscience drug development
4 min read
False
Advertisement
Top Stories
Browse By Topic
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
Voices in the Community
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
FOYA: Celebrating Innovation in Pharma Facilities
We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.
Latest News
All the latest Medicine Maker articles.
Why Refrigerants Are the Next Critical Sustainability Frontier
June 18, 2026
With stricter regulations on the horizon, biopharma labs are being forced to rethink how they cool, store, and protect critical samples
5 min read
Collaboration is the Key to Democratizing Advanced Therapies
June 17, 2026
Why no single player can solve the scalability challenge alone
4 min read
Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice
June 16, 2026
The study points to a possible off-the-shelf cell therapy for solid tumors
2 min read
Stem Cells More Cost-Effective than Gene Therapy for Sickle Cell Disease
June 16, 2026
Researchers found gene therapy produced the highest modeled health benefit, but haploidentical stem cell transplantation offered better value at current prices
2 min read
Parabilis Sets Biotech IPO Record
June 15, 2026
The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement
1 min read
The Science of Listening
June 15, 2026
Why patient voices must shape rare disease innovation
4 min read
The Scalability Challenge in MSC Therapies
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
Roving Reporter Asks: What Emerging Approaches Could Define the Next Wave of Advanced Therapies?
June 11, 2026
IBTV speaks with industry leaders at Advanced Therapies London 2026 to explore the emerging modalities and technologies that could shape the next era of cell and gene therapy
AI in Drug Development: Moving Beyond Early Use Cases
June 10, 2026
As new rules take hold, what does “good AI practice” look like in drug development?
6 min read
This Week’s Biopharma News: Big Moves in Bispecifics
June 9, 2026
Akeso’s PD-1/VEGF bispecific beats PD-1 plus chemo in lung cancer, Amgen wins EC approval for its DLL3-targeted T-cell engager, and Aragen scales Renaissance’s Fast Track anti-GD2 antibody
4 min read
Newsletters
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.